• 1
    Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30: 120513.
  • 2
    Todd JA. From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays 1999;21: 16474.
  • 3
    Reveille JD. The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. Curr Opin Rheumatol 1992;4: 64456.
  • 4
    Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995;13: 179200.
  • 5
    Baxter AG, Mandel TE. Hemolytic anemia in non-obese diabetic mice. Eur J Immunol 1991;21: 20515.
  • 6
    Bernard NF, Ertug F, Margolese H. High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes 1992; 41: 406.
  • 7
    Krug J, Williams AJ, Beales PE et al. Parathyroiditis in the non-obese diabetic mouse – a new finding. J Endocrinol 1991;131: 1936.
  • 8
    Miyagawa J, Hanafusa T, Miyazaki A et al. Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the non-obese diabetic (NOD) mouse. Virchows Arch B Cell Pathol Incl Mol Pathol 1986;51: 21525.
  • 9
    Hu Y, Nakagawa Y, Purushotham KR, Humphreys-Beher MG. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am J Physiol 1992;263: E60714.
  • 10
    Wicker LS, Miller BJ, Coker LZ et al. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 1987;165: 163954.
  • 11
    Robinson CP, Yamachika S, Bounous DI et al. A novel NOD-derived murine model of primary Sjögren's syndrome. Arthritis Rheum 1998;41: 1506.
  • 12
    Wicker LS, Appel MC, Dotta F et al. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J Exp Med 1992;176: 6777.
  • 13
    Johansson AC, Nakken B, Sundler M et al. The genetic control of sialadenitis versus arthritis in a NOD.Q × b10.Q F2 Cross. Eur J Immunol 2002;32: 24350.
  • 14
    Rasooly L, Burek CL, Rose NR. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol 1996;81: 28792.
  • 15
    Wicker LS. Major histocompatibility complex-linked control of autoimmunity. J Exp Med 1997;186: 9735.
  • 16
    Amor S, Baker D, Groome N, Turk JL. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56–70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice. J Immunol 1993;150: 566672.
  • 17
    Bernard CC, Johns TG, Slavin A et al. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 1997;75: 7788.
  • 18
    Baxter AG, Horsfall AC, Healey D et al. Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 1994;83: 22731.
  • 19
    Johansson AC, Sundler M, Kjellen P et al. Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcgammaRIIb and is not associated with loci controlling diabetes. Eur J Immunol 2001;31: 184756.
  • 20
    Becker KG. The common genetic hypothesis of autoimmune/inflammatory disease. Curr Opin Allergy Clin Immunol 2001;1: 399405.
  • 21
    Becker KG. Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways? Diabetes 1999; 48: 13538.
  • 22
    Bergsteinsdottir K, Yang HT, Pettersson U, Holmdahl R. Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J Immunol 2000;164: 15648.
  • 23
    Holmdahl R. Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. Curr Opin Immunol 1998;10: 7107.
  • 24
    Prochazka M, Leiter EH, Serreze DV, Coleman DL. Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice[published erratum appears in Science 1988;242(4880):945]. Science 1987;237: 2869.
  • 25
    Lord CJ, Bohlander SK, Hopes EA et al. Mapping the diabetes polygene Idd3 on mouse chromosome 3 by use of novel congenic strains. Mamm Genome 1995;6: 56370.
  • 26
    Wicker LS, Todd JA, Prins JB et al. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J Exp Med 1994;180: 170513.
  • 27
    Denny P, Lord CJ, Hill NJ et al. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes 1997;46: 695700.
  • 28
    Colucci F, Bergman ML, Penha-Goncalves C, Cilio CM, Holmberg D. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci USA 1997;94: 86704.
  • 29
    Lyons PA, Hancock WW, Denny P et al. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 2000;13: 10715.
  • 30
    Hill NJ, Lyons PA, Armitage N et al. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 2000;49: 17447.
  • 31
    Podolin PL, Denny P, Lord CJ et al. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. J Immunol 1997;159: 183543.
  • 32
    Boulard O, Fluteau G, Eloy L et al. Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J Immunol 2002;168: 4192201.
  • 33
    Brayer J, Lowry J, Cha S et al. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy [In Process Citation]. J Rheumatol 2000;27: 1896904.
  • 34
    Cha S, Nagashima H, Brown VB, Peck AB, Humphreys-Beher MG. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background. Arthritis Rheum 2002;46: 13908.
  • 35
    Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981;154: 688700.
  • 36
    Lindqvist AK, Bockermann R, Johansson AC et al. Mouse models for rheumatoid arthritis. Trends Genet 2002;18: S713.
  • 37
    Ji H, Gauguier D, Ohmura K et al. Genetic influences on the end-stage effector phase of arthritis. J Exp Med 2001;194: 32130.
  • 38
    Wei XQ, Leung BP, Arthur HM, McInnes IB, Liew FY. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol 2001;166: 51721.
  • 39
    Theofilopoulos AN. The basis of autoimmunity. Part I. Mechanisms of aberrant self-recognition. Immunol Today 1995;16: 908.
  • 40
    Theofilopoulos AN. The basis of autoimmunity. Part II. Genetic predisposition. Immunol Today 1995;16: 1509.
  • 41
    Jordan MA, Silveira PA, Shepherd DP et al. Linkage analysis of systemic lupus erythematosus induced in diabetes-prone nonobese diabetic mice by Mycobacterium bovis. J Immunol 2000;165: 167384.
  • 42
    Becker KG, Simon RM, Bailey-Wilson JE et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998;95: 997984.
  • 43
    Kono DH, Burlingame RW, Owens DG et al. Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci USA 1994;91: 1016872.
  • 44
    Xie S, Chang S, Yang P et al. Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. J Immunol 2001;167: 71419.
  • 45
    Hogarth MB, Slingsby JH, Allen PJ et al. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J Immunol 1998;161: 275361.
  • 46
    Krause I, Tomer Y, Elias D et al. Inhibition of diabetes in NOD mice by idiotypic induction of SLE. J Autoimmun 1999;13: 4955.
  • 47
    Morel L, Blenman KR, Croker BP, Wakeland EK. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci USA 2001;98: 178792.
  • 48
    Vyse TJ, Rozzo SJ, Drake CG, Izui S, Kotzin BL. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice. J Immunol 1997;158: 556674.
  • 49
    Meeker ND, Hickey WF, Korngold R et al. Multiple loci govern the bone marrow-derived immunoregulatory mechanism controlling dominant resistance to autoimmune orchitis. Proc Natl Acad Sci USA 1995;92: 56848.
  • 50
    Svensson L, Jirholt J, Holmdahl R, Jansson L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998;111: 5216.
  • 51
    Tung KS, Teuscher C. Mechanisms of autoimmune disease in the testis and ovary. Hum Reprod Update 1995;1: 3550.
  • 52
    Boackle SA, Holers VM, Chen X et al. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 2001;15: 77585.
  • 53
    Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct fcgamma receptors [In Process Citation]. J Exp Med 2000;191: 16116.
  • 54
    Díaz de Ståhl T, Andrén M, Martinsson P, Verbeek JS, Kleinau S. Expression of FcγRIII is required for development of collagen-induced arthritis. Eur J Immunol 2002;32: 291522.
  • 55
    Bolland S, Yim YS, Tus K, Wakeland EK, Ravetch JV. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(-/-) mice. J Exp Med 2002;195: 116774.
  • 56
    McIndoe RA, Bohlman B, Chi E et al. Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci USA 1999;96: 22104.
  • 57
    Spinella DG, Jeffers JR, Reife RA, Stuart JM. The role of C5 and T-cell receptor Vb genes in susceptibility to collagen induced arthritis. Immunogenetics 1991;34: 237.
  • 58
    Mori L, De Libero G. Genetic control of susceptibility to collagen-induced arthritis in T cell receptor β-chain transgenic mice. Arthritis Rheum 1998;41: 25662.
  • 59
    Griffiths MM, Wang J, Joe B et al. Identification of four new quantitative trait loci regulating arthritis severity and one new quantitative trait locus regulating autoantibody production in rats with collagen-induced arthritis. Arthritis Rheum 2000;43: 127889.
  • 60
    Wang Y, Kristan J, Hao L et al. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 2000;164: 43407.
  • 61
    Wang Y, Rollins SA, Madri JA, Matis LA. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci USA 1995;92: 89559.
  • 62
    Andersson M, Goldschmidt TJ, Michaëlsson E, Larsson A, Holmdahl R. T cell receptor Vβ haplotype and complement C5 play no significant role for the resistance to collagen induced arthritis in the SWR mouse. Immunology 1991;73: 1916.
  • 63
    Wang Y, Nose M, Kamoto T, Nishimura M, Hiai H. Host modifier genes affect mouse autoimmunity induced by the lpr gene. Am J Pathol 1997;151: 17918.
  • 64
    Vidal S, Kono DH, Theofilopoulos AN. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J Clin Invest 1998;101: 696702.
  • 65
    Mohan C, Morel L, Yang P, Wakeland EK. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol 1997;159: 45465.
  • 66
    Drake CG, Babcock SK, Palmer E, Kotzin BL. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW) F1 mice. Proc Natl Acad Sci USA 1994;91: 40626.
  • 67
    Hirose S, Tsurui H, Nishimura H, Jiang Y, Shirai T. Mapping of a gene for hypergammaglobulinemia to the distal region on chromosome 4 in NZB mice and its contribution to systemic lupus erythematosus in (NZB × NZW) F1 mice. Int Immunol 1994;6: 185764.
  • 68
    Silveira PA, Baxter AG, Cain WE, Van Driel IR. A major linkage region on distal chromosome 4 confers susceptibility to mouse autoimmune gastritis. J Immunol 1999;162: 510611.
  • 69
    Brodnicki TC, McClive P, Couper S, Morahan G. Localization of Idd11 using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene. Immunogenetics 2000;51: 3741.
  • 70
    Rodrigues NR, Cornall RJ, Chandler P et al. Mapping of an insulin-dependent diabetes locus, Idd9, in NOD mice to chromosome 4. Mamm Genome 1994;5: 16770.
  • 71
    Nishihara M, Terada M, Kamogawa J et al. Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance. Arthritis Rheum 1999;42: 261623.
  • 72
    Van Blokland SC, Van Helden-Meeuwsen CG, Wierenga-Wolf AF et al. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis? Lab Invest 2000;80: 57585.
  • 73
    Rogner UC, Boitard C, Morin J, Melanitou E, Avner P. Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains. Genomics 2001;74: 16371.
  • 74
    Todd JA, Aitman T, Cornall R et al. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 1991;351: 5427.
  • 75
    Morahan G, McClive P, Huang D, Little P, Baxter A. Genetic and physiological association of diabetes susceptibility with raised Na+/H+ exchange activity. Proc Natl Acad Sci USA 1994;91: 5898902.
  • 76
    Ghosh S, Palmer SM, Rodrigues NR et al. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat Genet 1993;4: 4049.
  • 77
    Serreze DV, Prochazka M, Reifsnyder PC, Bridgett MM, Leiter EH. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J Exp Med 1994;180: 15538.
  • 78
    McAleer MA, Reifsnyder P, Palmer SM et al. Crosses of NOD mice with the related NON strain. A polygenic model for IDDM. Diabetes 1995;44: 118695.
  • 79
    Podolin PL, Denny P, Armitage N et al. Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3. Mamm Genome 1998;9: 2836.
  • 80
    Melanitou E, Joly F, Lathrop M, Boitard C, Avner P. Evidence for the presence of insulin-dependent diabetes-associated alleles on the distal part of mouse chromosome 6. Genome Res 1998;8: 60820.
  • 81
    Butterfield RJ, Blankenhorn EP, Roper RJ et al. Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am J Pathol 2000;157: 63745.
  • 82
    Jirholt J, Cook A, Emahazion T et al. Genetic linkage analysis of collagen-induced arthritis in the mouse. Eur J Immunol 1998;28: 33218.
  • 83
    Yang HT, Jirholt J, Svensson L et al. Identification of genes controlling collagen-induced arthritis in mice: striking homology with susceptibility loci previously identified in the rat. J Immunol 1999;163: 291621.
  • 84
    Fritz RB, Skeen MJ, Chou CH, Garcia M, Egorov IK. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J Immunol 1985;134: 232832.
  • 85
    Butterfield RJ, Blankenhorn EP, Roper RJ et al. Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. J Immunol 1999;162: 3096102.
  • 86
    Butterfield RJ, Sudweeks JD, Blankenhorn EP et al. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J Immunol 1998;161: 18607.
  • 87
    Blankenhorn EP, Butterfield RJ, Rigby R et al. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints. J Immunol 2000;164: 34205.
  • 88
    Encinas JA, Lees MB, Sobel RA et al. Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis. Int Immunol 2001;13: 25764.
  • 89
    Baker D, Rosenwasser OA, O'Neill JK, Turk JL. Genetic analysis of experimental allergic encephalomyelitis in mice. J Immunol 1995;155: 404651.
  • 90
    Jirholt J, Lindqvist AK, Karlsson J, Andersson A, Holmdahl R. Identification of susceptibility genes for experimental autoimmune encephalomyelitis that overcome the effect of protective alleles at the eae2 locus. Int Immunol 2002;14: 7985.
  • 91
    Sundvall M, Jirholt J, Yang HT et al. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet 1995;10: 3137.
  • 92
    Teuscher C, Butterfield RJ, Ma RZ et al. Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, alocus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. J Immunol 1999;163: 22626.
  • 93
    Weis JJ, McCracken BA, Ma Y et al. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J Immunol 1999;162: 94856.
  • 94
    Roper RJ, Weis JJ, McCracken BA et al. Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses. Genes Immun 2001;2: 38897.
  • 95
    Morel L, Mohan C, Yu Y et al. Multiplex inheritance of component phenotypes in a murine model of lupus. Mamm Genome 1999;10: 17681.
  • 96
    Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994;1: 21929.
  • 97
    Morel L, Tian XH, Croker BP, Wakeland EK. Epistatic modifiers of autoimmunity in a murine model of lupus nephritis. Immunity 1999;11: 1319.
  • 98
    Haywood ME, Hogarth MB, Slingsby JH et al. Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice. Arthritis Rheum 2000;43: 34955.
  • 99
    Otto JM, Cs-Szabo G, Gallagher J et al. Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis. Arthritis Rheum 1999;42: 252431.
  • 100
    Otto JM, Chandrasekeran R, Vermes C et al. A genome scan using a novel genetic cross identifies new susceptibility loci and traits in a mouse model of rheumatoid arthritis. J Immunol 2000;165: 527886.